Loading...

VATE INNOVATE CORP Expansion Plans 8-K Filing

NNVT

VT

INNOVATE CORP

(VATE)

2026 8-K

Merger Announcement

Earnings Release

Dividend Announcement

Device Approval Update

Earnings Release

Press Release Recognition

Dividend Announcement

FDA Approval Granted

Earnings Report

Regulatory Approval Received

Dividend Announcement

Growth Announcement

Financial Statements

Debt-Equity Swaps

Debt Restructuring

Increase in Dividend Rate

Debt Restructuring

Financial Statements

Earnings Announcement

Product Approval

Record Quarter Announcement

Earnings Announcement

NYSE Compliance

Reverse Stock Split

Earnings Reports

Unregistered Sales of Equit...

Adjournment of Annual Meeting

Earnings Reports

Unregistered Sales of Equit...

Extension of Rights Offering

Unregistered Sales of Equit...

Earnings Release

Earnings Reports

Appointment of Interim CEO

Departure of Chief Operatin...

Earnings Reports

Appointments, Resignations

Annual Meeting Voting Results

Earnings Reports

Amendment to Credit Agreement

Tax Benefits Preservation Plan

Sale of Equity Stake

Agreement, Compliance, Note...

External Links:

On March 31, 2026, INNOVATE Corp. announced that its MediBeacon® Transdermal GFR Monitor and Reusable Sensor received CE Mark approval under European Medical Device Regulation, enabling its market entry in Europe. This is a significant event for the company as it opens up new opportunities for their product in the European region.

AI Assistant

INNOVATE CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.